Is Bio-Rad Laboratories, Inc. overvalued?

Bio-Rad Laboratories, Inc. (BIO) looks overvalued — trading about 56% above its fair value.

Overvalued

Price

$381.00

Fair value

$166.46

Current P/E

41.1

Normal P/E

18.0

Market cap

$10.26B

Dividend yield

0.0%

Return on equity

3.2%

Sector

Healthcare

Fair value compares BIO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks